Thailand Orsiro Registry: Safety and Performance Registry for an all-comers patient population with the Limus Eluting Orsiro Stent System within daily clinical practice

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20180828006

Enrollment

150

Registered

2018-08-28

Start date

2018-12-21

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

all&#45

Interventions

This registry recruits subjects from an all comers patient population with all subjects requiring coronary revascularization with a Drug Eluting Stent (DES). The subgroups consist of subjects presenti

Health Services Research

subjects requiring coronary revascularization with a Drug Eluting Stent

Eligibility

Sex/Gender

All

Age

21 Years to No maximum

Inclusion criteria

Inclusion criteria: Symptomatic coronary artery disease Subject signed informed consent for data release Subject is willing to participate at all follow up assessments Subject is 21 years of age

Exclusion criteria

Exclusion criteria: Exclusion Criteria Subject did not sign informed consent for data release Known intolerance to aspirin, clopidogrel, ticlopidine, heparin or any other anticoagulation / antiplatelet therapy required for PCI, stainless steel, Sirolimus or contrast media Planned surgery within 6 months of PCI unless dual antiplatelet therapy will be maintained Pregnancy Currently participating in another study and primary endpoint is not reached yet.

Design outcomes

Primary

Measure	Time frame
Target Lesion Failure (TLF) at 12 months Composite of cardiac death, target vessel Q-wave or non-Q wave Myocardial Infarction (MI), Emergent	—

Secondary

Measure	Time frame
Target Lesion Failure (TLF) at 6 months 6 months follow up (FUP)	—

Contacts

Public ContactWacin Buddhari

Chulalongkorn University

wacin_buddhari@hotmail.com0-2256-4184

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026

Thailand Orsiro Registry: Safety and Performance Registry for an all&#45;comers patient population with the Limus Eluting Orsiro Stent System within daily clinical practice